Cytochrome P450 4F2
Definition:
References:
-
[1]. David E Stec, et al. Functional polymorphism in human CYP4F2 decreases 20-HETE production. Physiol Genomics. 2007 Jun 19;30(1):74-81. [Content Brief]
[2]. Y Kikuta, et al. Characterization of human liver leukotriene B(4) omega-hydroxylase P450 (CYP4F2). J Biochem. 2000 Jun;127(6):1047-52. [Content Brief]
[3]. Valérie Le Quéré, et al. Human CYP4F3s are the main catalysts in the oxidation of fatty acid epoxides. J Lipid Res. 2004 Aug;45(8):1446-58. [Content Brief]
[4]. Y Kikuta, et al. Cloning and expression of a novel form of leukotriene B4 omega-hydroxylase from human liver. FEBS Lett. 1994 Jul 4;348(1):70-4. [Content Brief]
[5]. R Jin, et al. Role of human CYP4F2 in hepatic catabolism of the proinflammatory agent leukotriene B4. Arch Biochem Biophys. 1998 Nov 1;359(1):89-98. [Content Brief]
[6]. Madhurima Dhar, et al. Omega oxidation of 3-hydroxy fatty acids by the human CYP4F gene subfamily enzyme CYP4F11. J Lipid Res. 2008 Mar;49(3):612-24. [Content Brief]
[7]. Robert-Jan Sanders, et al. Characterization of the human omega-oxidation pathway for omega-hydroxy-very-long-chain fatty acids. FASEB J. 2008 Jun;22(6):2064-71. [Content Brief]
[8]. Matthew G McDonald, et al. CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant. Mol Pharmacol. 2009 Jun;75(6):1337-46. [Content Brief]
[9]. Katheryne Z Edson, et al. Cytochrome P450-dependent catabolism of vitamin K: ω-hydroxylation catalyzed by human CYP4F2 and CYP4F11. Biochemistry. 2013 Nov 19;52(46):8276-85. [Content Brief]
[10]. Cristiano Fava, et al. The V433M variant of the CYP4F2 is associated with ischemic stroke in male Swedes beyond its effect on blood pressure. Hypertension. 2008 Aug;52(2):373-80. [Content Brief]
[11]. Timothy J Sontag, et al. Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status. J Biol Chem. 2002 Jul 12;277(28):25290-6. [Content Brief]
[12]. Maude Fer, et al. Cytochromes P450 from family 4 are the main omega hydroxylating enzymes in humans: CYP4F3B is the prominent player in PUFA metabolism. J Lipid Res. 2008 Nov;49(11):2379-89. [Content Brief]
[13]. J M Lasker, et al. Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. Role of Cyp4F2 and Cyp4A11. J Biol Chem. 2000 Feb 11;275(6):4118-26. [Content Brief]
[14]. Robert-Jan Sanders, et al. Omega-oxidation of very long-chain fatty acids in human liver microsomes. Implications for X-linked adrenoleukodystrophy. J Biol Chem. 2006 May 12;281(19):13180-13187. [Content Brief]